Haleon Plc Adr stock is traded at $9.05, with a volume of 11,882,273. It is down -1.63% in the last 24 hours and down -10.66% over the past month. Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Previous Close:
$9.20
Open:
$9.11
24h Volume:
11,882,273
Relative Volume:
0.59
Market Cap:
$39.67B
Revenue:
$14.54B
Net Income/Loss:
$2.22B
P/E Ratio:
18.58
EPS:
$0.4871
Net Cash Flow:
$2.58B
1W Performance:
-0.55%
1M Performance:
-10.66%
6M Performance:
-1.31%
1Y Performance:
-5.83%
1-Day Range:
$9.05$9.16
1-Week Range:
$9.05$9.34
52-Week Range:
$8.38$11.28
Haleon Plc Adr Stock (HLN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS